NONHUMAN HOST FOR P. FALCIPARUM

Sunday, 21st of November 2010 Print

NONHUMAN HOST FOR P. FALCIPARUM

From the International Herald Tribune and the Proceedings of National Academy of Sciences.

The latter is at www.pnas.gov, then type author's name in the search box.

Good reading.

BD

 

1)      LEARNING TO LIVE WITH MALARIA

By Sonia Shah

Published: October 8, 2010

It’s technically straightforward to eliminate malaria from an area. At least in theory. You reduce the ability of mosquitoes to bite people, treat every sick victim with curative drugs and prevent any infected person from bringing new parasites into the area. Keep working outwards from your area, and eventually there will be no more malaria.

But what if there’s a secret reservoir of pathogens in the bodies of wild animals, unreachable by medical interventions – as there is in yellow fever, cholera, and influenza, diseases from which humankind can never hope to be completely free?

In results reported in the Jan. 19 “Proceedings of the National Academy of Sciences,” a team of malariologists from France and Gabon have found just that. Using new methods of tracking malaria parasites, by subjecting samples of urine and feces to PCR analysis, the scientists found genetic traces of the most malignant malaria parasites – Plasmodium falciparum, presumed since the 1930s to be an exclusively human pathogen – inside the bodies of gorillas from Cameroon and Gabon.

There is also evidence from Vietnam and Malaysia that malaria parasites previously considered exclusive to monkeys can often be found utilizing human blood.

These discoveries of a possible wild reservoir for humankind’s most malignant malaria, some 130 years after the discovery of the malaria parasite, could mean that it will be impossible to eradicate malaria. When scientists discovered in the 1930s that monkeys carried yellow fever virus, they were forced to abandon hopes for eradicating yellow fever.

The realization will change anti-malaria work radically. Ever since the British army surgeon Ronald Ross and the Italian zoologist Giovanni Grassi discovered early in the 20th century that mosquitoes  transmitted malaria parasites, dreams of eradicating malaria have tantalized governments, public health leaders and philanthropists.

In 2007, Bill and Melinda Gates – whose foundation now sets the agenda in global health – announced that they intended to end malaria, an ambition that both the interagency Roll Back Malaria Partnership and the World Health Organization affirmed. Funds for the job have zoomed from $100 million a year in 1998 to nearly $2 billion by the end of 2009.

The Gates Foundation has given vaccine researchers $150 million since the late 1990s. There are dozens of experiments malaria vaccines in labs across the globe, with the most clinically advanced, Mosquirix, appearing to reduce the incidence of illness from malaria by 65 percent.

Oil companies such as Exxon Mobil, plagued by malaria in West Africa, have bankrolled genomics research at Western universities in search of new drugs. Even venture capitalists such as the former Microsoft executive Nathan Myhrvold have joined in.  He showed his laser mosquito-zapping system at a highly publicized lecture in February.

All hope to find a simple, permanent cure.

The new findings, however, challenge this dream. That is because eradicating a disease is, in several important respects, a goal diametrically opposed to controlling one.

When public health leaders want to control a disease, they devote the majority of their resources to the areas of greatest need. When their goal is eradication, they must spend their resources on areas where eradication is most likely – the areas with the least need.

If eradication campaigns fail, resources and political capital will have been lavished on the lowest priority areas with the lightest burdens.

That is precisely what happened when more than 90 nations signed up to a global malaria eradication campaign five decades ago, in schemes promoted by the U.S. State Department and the World Health Organization. After spending the modern equivalent of more than $9 billion, the campaign ended with malaria vanquished in a few island nations and in richer, more developed countries, leaving a much harder-to-control malaria still plaguing the poorest and most remote places. The W.H.O.'s Tibor Lepes called the failed eradication program “one of the greatest mistakes every made in public health.”

Successfully eradicating malaria would be a tremendous gain for the health of millions. And we will not know for sure whether wild species act as reservoirs and how that may affect eradication plans until more research is done.

But learning to live with malaria, forever, could lead to gains. While eradication requires abrupt interventions to break the cycle of transmission, sustained just long enough for the parasite to die out, learning to live with malaria means working to permanently sever the connections between mosquitoes and humans.

This means providing bed nets and cheap drugs in the short term, and building level roads, better drainage, sage water systems and mosquito-proof housing in the long term. At which point, it may not matter how many wild species carry the diseases, because humans will be largely malaria-free.

Sonia Shah is the author, most recently, of “The Fever: How Malaria has Ruled Humankind for 500,000 Years.”

2) NONHUMAN HOST FOR P. FALCIPARUM

 

Full text, with figures, at http://www.pnas.org/content/107/4/1458.full?sid=9ce48f6c-4fc3-40fc-a05b-24c7f1a0d815

 

PNAS

Proceedings of the National Academy of Sciences of the United States of America

 

African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum

1.   Franck Prugnolle a , 1 , 2 ,

2.   Patrick Durand a , 1 ,

3.   Cécile Neel b , c ,

4.   Benjamin Ollomo d ,

5.   Francisco J. Ayala e , 2 ,

6.   Céline Arnathau a ,

7.   Lucie Etienne b ,

8.   Eitel Mpoudi-Ngole c ,

9.   Dieudonné Nkoghe d ,

10. Eric Leroy d , f ,

11. Eric Delaporte b ,

12. Martine Peeters b , and

13. François Renaud a , 2

+ Author Affiliations

1.    aLaboratoire Génétique et Evolution des Maladies Infectieuses, Unité Mixte de Recherche 2724, Centre National de la Recherche Scientifique–Institut de Recherche pour le Développement, Institut de Recherche pour le Développement Montpellier, 34394 Montpellier Cedex 5, France;

2.    bUnité Mixte de Recherche 145, Virus de l’Immunodéficience Humaine/ Syndrome de l’ImmunoDéficience Acquise et Maladies Associées, Institut de Recherche pour le Développement and University of Montpellier 1, 34394 Montpellier, France;

3.    cInstitut de recherches Médicales et d’études des Plantes Médicinales Prévention du Sida au Cameroun Centre de Recherche Médicale, BP 906, Yaoundé, Cameroon;

4.    dUnité des Maladies Virales Émergentes, Centre International de Recherches Médicales de Franceville, BP 769, Franceville, Gabon;

5.    eDepartment of Ecology and Evolutionary Biology, University of California, Irvine, CA 92697-2525; and

6.    fEmergence des Pathologies Virales, Unité Mixte de Recherche 190, Institut de Recherche pour le Développement–Université de la Méditerranée, 13005 Marseille, France

1.     Contributed by Francisco J. Ayala, December 14, 2009 (sent for review October 27, 2009)

2.     1F.P. and P.D. contributed equally to this work.

 

Next Section

Abstract

Plasmodium reichenowi, a chimpanzee parasite, was until very recently the only known close relative of Plasmodium falciparum, the most virulent agent of human malaria. Recently, Plasmodium gaboni, another closely related chimpanzee parasite, was discovered, suggesting that the diversity of Plasmodium circulating in great apes in Africa might have been underestimated. It was also recently shown that P. reichenowi is a geographically widespread and genetically diverse chimpanzee parasite and that the world diversity of P. falciparum is fully included within the much broader genetic diversity of P. reichenowi. The evidence indicates that all extant populations of P. falciparum originated from P. reichenowi, likely by a single transfer from chimpanzees. In this work, we have studied the diversity of Plasmodium species infecting chimpanzees and gorillas in Central Africa (Cameroon and Gabon) from both wild-living and captive animals. The studies in wild apes used noninvasive sampling methods. We confirm the presence of P. reichenowi and P. gaboni in wild chimpanzees. Moreover, our results reveal the existence of an unexpected genetic diversity of Plasmodium lineages circulating in gorillas. We show that gorillas are naturally infected by two related lineages of parasites that have not been described previously, herein referred to as Plasmodium GorA and P. GorB, but also by P. falciparum, a species previously considered as strictly human specific. The continuously increasing contacts between humans and primate populations raise concerns about further reciprocal host transfers of these pathogens.

Plasmodium falciparum is the agent of malignant malaria, one of the worst scourges of mankind, with 2 million infant deaths and ∼500 million clinical cases per year, 85% in sub-Saharan Africa. Plasmodium reichenowi, a chimpanzee parasite, was the only known closely related sister lineage (Fig. 1A ), of which only one single exemplar was known (1, 2). It was assumed that the two parasites had evolved along with their hosts since the separation of the two lineages, ∼7 million years ago (the cospeciation hypothesis). The existence of only one P. reichenowi strain did not allow testing two alternative hypotheses: whether P. reichenowi was ancestral to P. falciparum or vice versa (1, 3). Recent genetic analysis of eight previously undescribed isolates of P. reichenowi from wild-born chimpanzees in Cameroon and Ivory Coast has shown that P. reichenowi is a geographically widespread and genetically diverse chimpanzee parasite and that P. falciparum is fully included within the much broader genetic diversity of P. reichenowi (4). Phylogenetic analysis indicates that all extant P. falciparum populations originated from P. reichenowi, likely by a single transfer from chimpanzees. Also recently, a unique closely related species, named Plasmodium gaboni, was discovered in two wild-born chimpanzees kept as pets in remote villages of Gabon (5), suggesting the possible existence of additional Plasmodium species infecting chimpanzees.

View larger version:

Fig. 1.

Phylogenetic relationships among Plasmodium species. (A) Before: Cytochrome b phylogeny based on gene sequences available before 2009. Only two species, P. falciparum, parasitic to humans, and P. reichenowi, parasitic to chimpanzees, were known within the clade that includes humans and the great apes (above). (B) This study: Phylogeny that includes the sequences obtained in our study. Three additional species are shown: P. gaboni, which infects chimpanzees (5), and P. GorA and P. GorB, which infect gorillas. Moreover, P. falciparum is shown to infect gorillas in addition to humans. The phylograms were constructed using a maximum-likelihood method from partial Cyt b sequence data (704 nucleotides). Bootstrap values are shown for the nodes inside the African great apes/human clade. (Scale bar, 0.03 substitutions per site.) cpm: Cheek-Push monkeys.

Although a number of Plasmodium species parasitic to apes and other primates have been identified, no primates have been studied systematically in their natural habitat owing to the difficulty of collecting blood samples. The recent discovery that Plasmodium can be genotyped from urine or saliva in humans (6, 7) and that fecal primate samples have allowed researchers to identify the ancestors of the HIV-1 epidemic in chimpanzees and gorillas (8, 9) moved us to explore whether similar noninvasive approaches could be used to investigate the diversity of malaria parasites in wild populations of apes (chimpanzees and gorillas) in Africa.

This is, indeed, the case. Thus, we have discovered (i) two unique gorilla parasites closely related to P. falciparum and (ii) that P. falciparum is not an exclusively human parasite, but can also infect gorillas.

Previous SectionNext Section

Results and Discussion

In the present study we analyzed fecal samples from wild chimpanzee (n = 125) and gorilla (n = 84) populations from eight distant localities in Cameroon (Fig. 2 and Materials and Methods ) and 3 blood samples from captive wild-born gorillas from Gabon. Using a Plasmodium-specific PCR assay, based on the mitochondrial Cytochrome b (Cyt b) gene, known to be suitable for exploring phylogenetic relationships in Plasmodium and related genera (1012), 22 chimpanzee samples and 18 gorilla samples (including 1 blood sample) were detected positive by PCR for Plasmodium (Tables S1 and S2). Unambiguous and good quality partial Cyt b sequences (704 nucleotides) were obtained for 5 chimpanzee and 7 gorilla samples. Failure to obtain good sequences from the remaining samples was mainly due to insufficient amplified DNA for sequencing (due to scarce Plasmodium DNA within the DNA extracted from feces).

View larger version:

Fig. 2.

Location of the wild chimpanzee and gorilla populations in Cameroon. The Sanaga River defines the boundary between P. t. troglodytes in the south and P. t. vellerosus in the north. G. g. gorilla is found in the south of Cameroon and G. g. diehli in the northwest of Cameroon at the border with Nigeria. BQ, CP, DP, MB, MF, MG, MP, TK: Sites of chimpanzee and gorilla feces collection (more details in Table S1).

Fig. 1B displays the phylogenetic relationships of the newly identified Plasmodium strains infecting the two host primates, obtained by maximum-likelihood methods ( Materials and Methods ). It may be noted, at the outset, that all nucleotide sequences in our study represented in Fig. 1B translated well into proteins, without any stop codons in the partial Cyt b gene sequence.

As recently observed (4), there is a much greater genetic diversity in chimpanzee parasites than among the numerous strains representing the global populations of human P. falciparum (Fig. S1). We have now identified in southeast Cameroon two unique chimpanzee isolates (MB753 and MB783), genetically very similar to the previous chimpanzee isolates from Gabon, named P. gaboni (5) (Fig. 1B ). A supplementary phylogenetic analysis (based on partial Cyt b sequences of 350 nucleotides in length, Fig. 3) including the Cyt b sequences recently published by Rich et al. (4) also shows that three of their isolates collected in Cameroon and Ivory coast (Bana, Max, and Loukoum) belong to the P. gaboni lineage, as previously suggested (4). Thus, P. gaboni is widespread, present in at least three different countries (Gabon, Cameroon, and Ivory Coast), and it infects at least two different chimpanzee subspecies (Pan troglodytes troglodytes in Gabon and Cameroon and Pan troglodytes verus in Ivory Coast). We have also identified two unique Plasmodium specimens from Cameroon (MP1309 and BQ642) that cluster with the reference sequence of P. reichenowi (Figs. 1B and 3). One specimen is from the MP locality (Fig. 2), north of the Sanaga river, a region home to the Pan troglodytes vellerosus chimpanzee subspecies; the other specimen is from the BQ site, north of the Dja Reserve (south-central Cameroon), which is home to the P. t. troglodytes subspecies. P. reichenowi is, therefore, geographically widespread (Cameroon and Ivory Coast) and infects three chimpanzee subspecies (P. t. troglodytes, P. t. vellerosus, and P. t. verus).

View larger version:

Fig. 3.

Phylogeny of Plasmodium species including our samples and those from Rich et al. (4), i.e., “reichenowi_isolate.” This phylogram was constructed using maximum likelihood from partial Cyt b sequence data (i.e., 350 nucleotides shared between the two studies). Bootstrap values were obtained using 100 iterations. (Scale bar, 0.05 substitutions per site.) P. reichenowi* corresponds to the reference GenBank sequence (Table S2).

In gorillas, we have identified two unique and previously unknown lineages of parasites (Fig. 1B ). One lineage, which is closely related to, but statistically distinct (bootstrap value = 88) from P. reichenowi and P. falciparum, includes two specimens (BQ2341 and BQ668) from the BQ locality. We hereafter refer to this lineage as Plasmodium GorB. The second lineage (referred as Plasmodium GorA) is closer to, but statistically different from P. gaboni (bootstrap value = 99). It includes three isolates (two from the BQ locality, BQ2367 and BQ638) and one from CP (CP1426), in the Campo Ma’an reserve in southwest Cameroon (Fig. 2). Surprisingly, we also identified P. falciparum in fecal samples from two gorillas in Cameroon and in one blood sample from a captive gorilla from Gabon. These three P. falciparum positive samples were collected in three different geographic localities and from two different gorilla subspecies: The TK site in western Cameroon is home to the highly endangered cross-river gorilla (Gorilla gorilla dielhi) and the samples collected just above the Dja Reserve (BQ) in Cameroon and Gabon were from western lowland gorillas (Gorilla gorilla gorilla).

In summary, we have identified Plasmodium infections in five of the eight localities studied in Cameroon. At least five different Plasmodium lineages (including P. falciparum, P. reichenowi, P. gaboni, P. GorA, and P. GorB) circulate among apes in Cameroon; four of them occur in BQ, within a small geographic area (of ∼15 km2). The frequency of positive fecal samples (22 of 125 for chimpanzees and 18 of 84 for gorillas) is high, which demonstrates the high prevalence of Plasmodium infections in apes in their natural habitat, as well as the suitability of this noninvasive method to study Plasmodium infection in wild animals.

Coatney et al. (13) and Garnham (14) reported several forms of Plasmodium infecting gorillas, including P. reichenow, Plasmodium rodhaini, and Plasmodium schwetzi, although none of them was genetically characterized. It is possible that some of the parasites previously identified as P. reichenowi may have been P. GorB or P. GorA parasites, given their genetic proximity to P. reichenowi. However, P. rodhaini and P. schwetzi are unlikely to correspond to the two newly identified gorilla lineages, because they are morphologically related to Plasmodium vivax and Plasmodium malariae, two human parasites, which, like Plasmodium ovale, another human parasite, belong to very distant evolutionary lineages (Fig. 1 A and B ; refs. 1 and 35).

Are P. GorA and P. GorB lineages two unique species of Plasmodium? Three broad classes of criteria can be used to define species for sexually reproducing organisms: the similarity species concept, which is based on phenotypic features; the biological or reproductive species concept, which focuses on the ability of sexually reproducing organisms to cross and produce fertile offspring; and the phylogenetic or lineage-based species concept, which emphasizes shared evolutionary history of individuals (15, 16). Species of malaria have traditionally been described using the similarity species concept based primarily on differences in morphology, life-history traits, species of hosts infected, and/or symptoms of infection (13, 14). Whereas this approach has been useful, it has now proved to be unreliable for several reasons. First, parasite morphology may be altered during blood smear preparation (which may result in artifactual differences in the appearance of the parasite under the light microscope, ref. 16) and, second, morphology and life history traits may vary depending on the host species in which the parasites find themselves (17, 18). The similarity species concept may, therefore, lead to the splitting of true species on the basis of phenotypic differences, but also to the lumping of taxa that show morphological similarities (16). Species should ideally be identified using all three criteria listed above, but in practice this is often not easily feasible. In the present case, our results clearly indicate that P. GorA and P. GorB constitute two distinct monophyletic lineages, which could justify the definition of two unique species. However, we submit that it is prudent to gather additional information about these lineages before identifying them as different species. Perhaps, at a minimum, it will be appropriate to obtain their complete mitochondrial sequences, as was previously done for P. gaboni (5), before deciding to define it as a separate species.

The evolutionary origin of the ape–human clades A and B (Fig. 1B ) remains to be determined, but it is apparent that the origin of P. falciparum is within clade B, which includes P. reichenowi and P. GorB. Our results corroborate the recent proposal (4) that P. falciparum likely originated from P. reichenowi following a host transfer (Fig. 3).

It has been assumed that P. falciparum is strictly a human-specific pathogen. First, experimental infections with human blood infected with P. falciparum fail to induce malaria in chimpanzees (review in ref. 13). Even after splenectomy to increase parasite survival, experimentally infected chimpanzees do not develop a parasitemia equivalent to that observed in humans (13, 19). Second, captive chimpanzees in Gabon do not get infected with P. falciparum despite high rates of infection among their keepers and being exposed to the same vector mosquitoes (20). Finally, Martin, Varki, and colleagues (21, 22) have shown that the strong human specificity of P. falciparum may be linked to species-specific erythrocyte recognition profiles. The human-specific loss of the common primate Sia N-glycolylneuraminic acid (Neu5Gc) would have protected our human ancestors from P. reichenowi. Consequently, however, the major merozoite-binding protein, the erythrocyte-binding antigen-175 (EBA 175) of P. falciparum, would have evolved to take advantage of the accumulated excess on human erythrocytes of the Neu5Gc precursor, the Sia N-acetylneuraminic acid (Neu5Ac).

Our observations challenge the assumed human specificity of P. falciparum. We have detected P. falciparum in three gorillas from three different localities. This might be because the gorilla erythrocyte has both the Neu5Ac and the Neu5Gc forms of sialic acids (23), including the Neu5Ac form that the P. falciparum parasite prefers to bind to (21). However, the density of Neu5Ac may be much lower in gorilla cells (23), which could account for the rare observation of P. falciparum in gorilla samples. In any case, our results raise the distinct possibility that gorillas may be a reservoir for the very virulent parasite, P. falciparum. The amplification and characterization of P. falciparum from the blood and/or the feces of the three gorillas were carried out under very stringent conditions to exclude the possibility that the P. falciparum isolates were due to contamination with human strains. DNA extraction, amplification, and sequencing were repeated several times for each sample. One repetition was performed independently as a “blind test” in a Plasmodium-free laboratory (additional details in Materials and Methods ).

The likely success of the campaigns to eradicate malaria is hardly in sight. One consideration to keep in mind as the campaigns proceed is that gorillas (and perhaps other primates) may serve as a reservoir for malignant malaria and the possibility that humans might acquire P. falciparum by host transfer from gorillas. Our observations do not determine whether the three gorilla carriers of P. falciparum acquired the parasite from humans (or from other primates), nor do we know the pathogenicity of these infections in gorillas. The three infected gorillas come from distant localities, which makes it unlikely that they are accidental or recent infections. Independent foci of P. falciparum may be active in natural populations of gorillas in Central Africa. It should be noted, in addition, that P. malariae, a human parasite considerably less widespread and malignant than P. falciparum, has recently been found in two captive asymptomatic chimpanzees that were exported to Japan ∼30 years ago (19). The authors propose that the P. malariae isolates were exported from Africa to Japan with their hosts (19).

In conclusion, molecular tools and noninvasive sampling strategies have allowed us to discover a great diversity of Plasmodium species circulating in wild apes from Central Africa and the fragility of species barriers against the transmission of vector-borne pathogens, at least in primates. Our results enlarge the diversity of species within the clade that previously included only two species, P. falciparum and P. reichenowi, with the addition of two unique Plasmodium lineages parasitic to gorillas and the confirmation of our recently discovered chimpanzee parasite, P. gaboni (5). The continuously increasing contact between humans and primate populations, mostly due to logging and deforestation, increases the possibility of transmission of new pathogens from primates to humans and from humans to primates, including the endangered great apes.

Previous SectionNext Section

Materials and Methods

Origin of Samples and Blood and Feces Collection.

We analyzed blood and fecal samples collected from chimpanzees and gorillas in Gabon and Cameroon. In Cameroon, only fecal samples from wild chimpanzees and gorillas were analyzed (Fig. 3). The fecal samples were obtained from existing banks of specimens previously collected for molecular epidemiological studies of SIVcpz and SIVgor (9, 24). For chimpanzees, fecal samples were analyzed from two subspecies, P. t. troglodytes (n = 90) and P. t. vellerosus (n = 35) (Table S1). For gorillas, we analyzed populations of the cross-river subspecies G. g. diehli (northwest of Cameroon, near the Nigeria border, TK in Fig. 2) (n = 12) and the western lowland subspecies G. g. gorilla (other localities in Cameroon) (n = 72) (Table S1). Samples were preserved in RNAlater, shipped, and processed as described (8). All fecal samples were collected in the wild, and the species and subspecies (for chimpanzees only) were confirmed by mitochondrial DNA analysis as reported (8). In Gabon, blood aliquots from three gorillas (G. g. gorilla) were collected. The samples were collected from wild-born animals kept in a sanctuary on island Evaro, near Lambaréné, Moyen-Ogooué. This investigation was approved by the Government of the Republic of Gabon and by the Animal Life Administration of Libreville, Gabon (no. CITES 00956). All animal work was conducted according to relevant national and international guidelines. Blood samples were collected in 7-mL EDTA vacutainers from gorillas under ketamine anesthesia. Clots and plasma were obtained by centrifugation and stored at −20 °C until they were transported to the Centre International de Recherches Médicales de Franceville (CIRMF), Gabon, where they were stored at −80 °C until they were processed for testing.

DNA Extraction, PCR Conditions, and Sequencing.

Total DNA (Plasmodium and host) was isolated and purified from blood using the DNeasy blood kit (Qiagen) according to the manufacturer’s instructions. Fecal DNA was extracted using the QIAamp DNA Stool Mini Kit (Qiagen) as described (8).

The Plasmodium Cytochrome b (Cyt b) gene was amplified using published primers (12, 25, 26). A nested PCR was performed using an MJ Research PTC100 thermal cycler or Mastercycler Eppendorf thermocycler. For the first round of amplifications, we used 4 μL of DNA template in a 25-μL reaction volume, containing: 12.5 μL of Mix PCR (Qiagen), 2.5 μL solution Q (Qiagen), and 2 pmol of each primer (DW2 and DW4). Cycling conditions were 3 min at 94 °C, 20 s at 94 °C, 20 s at 60 °C, 90 s at 72 °C (35 cycles), and 10 min at 72 °C. For the second round of amplification, we used 1 μL of the first PCR template in a 25-μL reaction volume, containing 2.5 μL of 10× buffer, 1.25 mM MgCl2, 250 μM of each dNTP, 37.5 pmol of each primer (Pfcyb1 and Pfcytb2), and 0.5 unit Taq DNA polymerase (Invitrogen). Cycling conditions for the second round were 5 min at 95 °C, 30 s at 94 °C, 30 s at 50 °C, 90 s at 72 °C (35 cycles), and 10 min at 72 °C.

The amplified products (5 μL) were run on 1.5% agarose gels in TAE buffer. The PCR-amplified products were used as templates for sequencing. DNA sequencing was performed by CoGenics Genome Express.

For fecal samples positive for the same Plasmodium species/genetic entities and collected in the same site, we used microsatellite markers specific for chimpanzees and gorillas to determine if they originated from the same host individual or different ones (8).

Prevention of PCR Contaminations and Confirmation of Results in a “Plasmodium Free” Laboratory.

To avoid PCR contaminations, we followed strict rules for DNA extraction and PCR: (i) All DNA extractions were done in a laboratory where no work is conducted on Plasmodium to prevent contamination of the native DNA [Unité Mixte de Recherche 145, Laboratory SIV/HIV et Maladies Associées, Institut de Recherche pour le Développement (IRD), Montpellier, France]. Extractions were made in a P3 laboratory, under a laminar flow safety cabinet reserved for the treatment of primate samples (human samples are never manipulated under this hood). (ii) For the first set of amplifications, we did all PCRs in the laboratory Génétique et Evolution des Maladies Infectieuses (GEMI, IRD, Montpellier, France). The amplifications were done on Mastercycler Eppendorf Thermocyclers. In all steps of PCR preparation we used specially assigned lab coats, gloves, and filter tips, as well as DNA-RNase-free water (Qiagen). All PCR mixes were prepared in a single room under a safety hood with UV light, using pipettes dedicated to the preparation of the PCR mix. DNA templates were deposited in a second room. PCR cycles on thermocyclers were performed in a third room. Electrophoreses of the PCR products were realized in a fourth room. (iii) For all samples positive for P. falciparum or any other Plasmodium, DNA extractions, PCR, and sequencing were repeated. PCRs were done in a Plasmodium-free laboratory working on rice (Laboratory Diversité et Génome des Plantes Cultivées, IRD, Montpellier, France). For each newly extracted sample, four PCR replicates were done the same day on a PTC100 MJ Research Thermocycler. A master mix was prepared in a hood with laminar flow using a new set of micropipettes, new aerosol-resistant pipette tips, new PCR reagents, new primers, and new DNA-RNase-free water.

For this second set of amplifications, all manipulations were carried out blindly (all tubes were initially randomized on the plate by a third person). Six DNA templates negative to Plasmodium were also randomly distributed among the samples to be amplified. Negative controls with water instead of DNA were tested for each PCR.

In all cases (first and second sets of amplification), we never detected any band in the negative template controls.

Alignment and Phylogenetic Analyses.

For phylogenetic analyses we used, in addition to our sequences, 18 previously published Cyt b sequences from different Plasmodium species (Cyt b sequence length: 704 nucleotides). Hosts and GenBank accession numbers for these taxa are given in Table S2. An additional set of phylogenetic analyses was performed using the same 18 previously published sequences, but also adding sequences recently published by Rich et al. (4). Because our Cyt b sequences and those from Rich et al. (4) only partially overlapped, the final length of the sequences used for this latter analysis was shorter (i.e., 350 nucleotides). The multiple alignment of all partial Cyt b sequences was conducted using ClustalW (v 1.8.1 in BioEdit v.7.0.9.0. software) (27).

Maximum-likelihood (ML) tree construction was based on the Cyt b sequences. The best-fitting ML model under the Akaike information criterion was general time reversible plus Gamma distribution (GTR + Γ) for nucleotides as identified by ModelTest (28). The highest-likelihood DNA trees and corresponding bootstrap support values were obtained by PhyML (freely available at the ATGC bioinformatics platform http://www.atgc-montpellier.fr/), using nearest neighbor interchange plus subtree pruning regrafting (NNI + SPR) branch swapping and 100 bootstrap replicates (29).

Previous SectionNext Section

Acknowledgments

We thank Alison Ducan for critical reading of a previous version of the manuscript and Michel Brunet for helpful discussions. We thank Philippe Yaba, André Délicat, Paul Ngari, and Philippe Engandja for technical support in the field. We thank Michel Nicole and Denis Fargette for allowing us to perform some of our manipulations in their laboratory. We thank the Cameroonian Ministries of Health, Environment and Forestry, and Research and the staff from the Prévention du Sida au Cameroun project for logistical support and Innocent Ndong Bass and Aimé Mebanga for collection of samples in the field. Finally, we thank two referees for their constructive comments. Funding was provided by the French Institut de Recherche pour le Développement, Centre National de la Recherche Scientifique, Centre International de Recherches Médicale de Franceville, a Fonds de Solidarité Prioritaire grant from the Ministère des Affaires Etrangères de la France (Fonds de Solidarité Prioritaire 2002005700), the program Maladies Infectieuses Emergentes–Centre National de la Recherche Scientifique (Maladies Infectieuses Emergentes 2009), and the Agence Nationale de Recherches sur le Syndrome de l’ImmunoDéficience Acquise, France (Grants ANRS 12125 and 12182). Centre International de Recherches Médicale de Franceville is supported by the Government of Gabon and Total-Fina-Elf Gabon.

Previous SectionNext Section

Footnotes

  • 2To whom correspondence may be addressed. E-mail: prugnoll@mpl.ird.fr, frrenaud@mpl.ird.fr, or fjayala@uci.edu.
  • Author contributions: F.P., P.D., E.L., E.D., M.P., and F.R. designed research; F.P., P.D., C.N., B.O., C.A., L.E., E.M.-N., D.N., and E.L. performed research; F.P., P.D., and F.R. analyzed data; and F.P., P.D., F.J.A., E.D., M.P., and F.R. wrote the paper.
  • The authors declare no conflict of interest.
  • Data deposition: The sequences reported in this paper have been deposited in the GenBank database. For a list of accession numbers, see Table S2.
  • This article contains supporting information online at www.pnas.org/cgi/content/full/0914440107/DCSupplemental.

Previous Section

 

References

1.   

1.    Escalante AA,

2.    Barrio E,

3.    Ayala FJ

(1995) Evolutionary origin of human and primate malarias: Evidence from the circumsporozoite protein gene. Mol Biol Evol 12:616–626.

Abstract

2.   

1.    Jeffares DC,

2.    et al.

(2007) Genome variation and evolution of the malaria parasite Plasmodium falciparum Nat Genet 39:120–125.

CrossRefMedlineWeb of Science

3.   

1.    Escalante AA,

2.    Ayala FJ

(1995) Evolutionary origin of Plasmodium and other Apicomplexa based on rRNA genes. Proc Natl Acad Sci USA 92:5793–5797.

Abstract/FREE Full Text

4.   

1.    Rich SM,

2.    et al.

(2009) The origin of malignant malaria. Proc Natl Acad Sci USA 106:14902–14907.

Abstract/FREE Full Text

5.   

1.    Ollomo B,

2.    et al.

(2009) A new malaria agent in African hominids. PLoS Pathog 5:e1000446.

CrossRefMedline

6.   

1.    Mharakurwa S,

2.    Simoloka C,

3.    Thuma PE,

4.    Shiff CJ,

5.    Sullivan DJ

(2006) PCR detection of Plasmodium falciparum in human urine and saliva samples. Malar J 5:103.

CrossRefMedline

7.   

1.    Nwakanma DC,

2.    et al.

(2009) Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. J Infect Dis 199:1567–1574.

CrossRefMedlineWeb of Science

8.   

1.    Keele BF,

2.    et al.

(2006) Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313:523–526.

Abstract/FREE Full Text

9.   

1.    Van Heuverswyn F,

2.    et al.

(2006) Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 444:164.

CrossRefMedline

10. 

1.    Escalante AA,

2.    Freeland DE,

3.    Collins WE,

4.    Lal AA

(1998) The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci USA 95:8124–8129.

Abstract/FREE Full Text

11. 

1.    Hagner SC,

2.    Misof B,

3.    Maier WA,

4.    Kampen H

(2007) Bayesian analysis of new and old malaria parasite DNA sequence data demonstrates the need for more phylogenetic signal to clarify the descent of Plasmodium falciparum Parasitol Res 101:493–503.

CrossRefMedlineWeb of Science

12. 

1.    Perkins SL,

2.    Schall JJ

(2002) A molecular phylogeny of malarial parasites recovered from cytochrome b gene sequences. J Parasitol 88:972–978.

CrossRefMedline

13. 

1.    Coatney GR,

2.    Collins WE,

3.    Warren M,

4.    Contacos PG

(1971) The Primate Malarias (US Government Printing Office, Washington, DC).

14. 

1.    Garnham PCC

(1966) Malaria Parasites and Other Haemosporidia (Blackwell Scientific, Oxford).

15. 

1.    Tibayrenc M

(2006) The species concept in parasites and other pathogens: A pragmatic approach? Trends Parasitol 22:66–70.

CrossRefMedlineWeb of Science

16. 

1.    Perkins SL

(2000) Species concepts and malaria parasites: Detecting a cryptic species of Plasmodium. Proc Biol Sci 267:2345–2350.

Abstract/FREE Full Text

17. 

1.    Jordan HB

(1975) The effect of host constitution on the development of Plasmodium floridense J Eukaryot Microbiol 22:241–244.

CrossRef

18. 

1.    Manwell RD

(1943) Malaria infections by four species of plasmodium in the duck and chicken, and resulting parasite modifications. Am J Epidemiol 38:211–222.

FREE Full Text

19. 

1.    Taylor DW,

2.    et al.

(1985) Parasitologic and immunologic studies of experimental Plasmodium falciparum infection in nonsplenectomized chimpanzees (Pan troglodytes) Am J Trop Med Hyg 34:36–44.

Abstract/FREE Full Text

20. 

1.    Ollomo B,

2.    et al.

(1997) Lack of malaria parasite transmission between apes and humans in Gabon. Am J Trop Med Hyg 56:440–445.

Abstract/FREE Full Text

21. 

1.    Martin MJ,

2.    Rayner JC,

3.    Gagneux P,

4.    Barnwell JW,

5.    Varki A

(2005) Evolution of human-chimpanzee differences in malaria susceptibility: Relationship to human genetic loss of N-glycolylneuraminic acid. Proc Natl Acad Sci USA 102:12819–12824.

Abstract/FREE Full Text

22. 

1.    Varki A,

2.    Gagneux P

(2009) Human-specific evolution of sialic acid targets: Explaining the malignant malaria mystery? Proc Natl Acad Sci USA 106:14739–14740.

FREE Full Text

23. 

1.    Muchmore EA,

2.    Diaz S,

3.    Varki A

(1998) A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol 107:187–198.

CrossRefMedlineWeb of Science

24. 

1.    Van Heuverswyn F,

2.    et al.

(2007) Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Virology 368:155–171.

CrossRefMedlineWeb of Science

25. 

1.    Conway DJ,

2.    et al.

(2000) Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA. Mol Biochem Parasitol 111:163–171.

CrossRefMedlineWeb of Science

26. 

1.    Schwobel B,

2.    Alifrangis M,

3.    Salanti A,

4.    Jelinek T

(2003) Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: Rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. Malar J 2:2.

CrossRefMedline

27. 

1.    Hall TA

(1999) BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98.

28. 

1.    Posada D,

2.    Crandall KA

(1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817–818.

Abstract/FREE Full Text

29. 

1.    Guindon S,

2.    Gascuel O

(2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696–704.

Abstract/FREE Full Text

Articles citing this article

  • Allele Frequency-Based and Polymorphism-Versus-Divergence Indices of Balancing Selection in a New Filtered Set of Polymorphic Genes in Plasmodium falciparum Mol Biol Evol 2010 27 (10) 2344-2351

o    Abstract

o    Full Text

o    Full Text (PDF)

  • African apes as reservoirs of Plasmodium falciparum and the origin and diversification of the Laverania subgenus Proc. Natl. Acad. Sci. USA 2010 107 (23) 10561-10566

o    Abstract

o    Full Text

o    Full Text (PDF)

  • That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda Science 2010 328 (5980) 862-866

o    Abstract

o    Full Text

o    Full Text (PDF)

 


24377890